Literature DB >> 23345497

Old drugs: new complications.

Sandeep Batra1, Jyoti Wadhwa, Ashok K Vaid, Neelam Sharma.   

Abstract

This is a case of acute splenic and bilateral renal infarction in a patient with non-small cell lung carcinoma during chemotherapy with gemcitabine and cisplatin. Till date, bilateral renal infarction following gemcitabine and cisplatin has been reported only once in the past. The case that is being reported has had acute splenic and bilateral renal infarct and has not been reported previously. Splenic and renal infarction should be considered in the differential diagnosis of excruciating abdominal pain and backache in a patient on gemcitabine-based and cisplatin-based chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23345497      PMCID: PMC3604498          DOI: 10.1136/bcr-2012-008066

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.

Authors:  C C Berger; C Bokemeyer; M Schneider; M A Kuczyk; H J Schmoll
Journal:  Eur J Cancer       Date:  1995-12       Impact factor: 9.162

Review 2.  Development of gemcitabine in non-small cell lung cancer: the Italian contribution.

Authors:  G Metro; F Cappuzzo; G Finocchiaro; L Toschi; L Crinò
Journal:  Ann Oncol       Date:  2006-05       Impact factor: 32.976

3.  Clinical characteristics of patients with segmental renal infarction.

Authors:  Pei-Lun Chu; Yu-Feng Wei; Jenq-Wen Huang; Shih-I Chen; Tzong-Shinn Chu; Kwan-Dun Wu
Journal:  Nephrology (Carlton)       Date:  2006-08       Impact factor: 2.506

4.  Idiopathic renal infarction.

Authors:  Rob Bolderman; Raymond Oyen; Anton Verrijcken; Daniël Knockaert; Steven Vanderschueren
Journal:  Am J Med       Date:  2006-04       Impact factor: 4.965

5.  Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine.

Authors:  Gianmauro Numico; Ornella Garrone; Vincenzo Dongiovanni; Nicola Silvestris; Ida Colantonio; Gianna Di Costanzo; Cristina Granetto; Marcella Occelli; Elena Fea; Abdelamid Heouaine; Milena Gasco; Marco Merlano
Journal:  Cancer       Date:  2005-03-01       Impact factor: 6.860

6.  Cisplatin triggers platelet activation.

Authors:  G I Togna; A R Togna; M Franconi; L Caprino
Journal:  Thromb Res       Date:  2000-09-01       Impact factor: 3.944

7.  Bilateral renal infarction in a patient with lung carcinoma treated with cisplatin and gemcitabine.

Authors:  Caner Cavdar; Omer Toprak; Ilhan Oztop; Mustafa Secil; Suna Cokmert; Taner Camsari
Journal:  Ren Fail       Date:  2007       Impact factor: 2.606

Review 8.  Severe vascular toxicity associated with cisplatin-based chemotherapy.

Authors:  F Içli; H Karaoğuz; D Dinçol; A Demirkazik; N Günel; R Karaoğuz; A Uner
Journal:  Cancer       Date:  1993-07-15       Impact factor: 6.860

9.  Increasing-dose gemcitabine plus low-dose cisplatin in metastatic non-small cell lung cancer.

Authors:  Angel Artal-Cortés; Javier Martínez-Trufero; Ana Herrero; Teresa Puértolas; Vicente Alonso; Mónica Corral; Concepción Ceballos; Joan Maurel; Antonio Antón
Journal:  Anticancer Drugs       Date:  2003-02       Impact factor: 2.248

Review 10.  Vascular toxicity associated with antineoplastic agents.

Authors:  D C Doll; J W Yarbro
Journal:  Semin Oncol       Date:  1992-10       Impact factor: 4.929

View more
  1 in total

1.  Bilateral macular infarction after gemcitabine and carboplatin chemotherapy.

Authors:  Umesh Chandra Behera; Rohit R Modi; Jenil Sheth; Arshi Singh
Journal:  Int Ophthalmol       Date:  2017-08-23       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.